Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Evaluation of rolipram in experimental animal models of colitis

June 5, 1998

FDA approves new combination therapy product for HCV

June 4, 1998

FDA advisory committee recommends approval of Avakine for Crohn's disease

May 29, 1998

Review study finds mesalamine most effective treatment for ulcerative colitis

May 29, 1998

Fujisawa presents new cephalosporin with good anti-H. pylori activity

May 28, 1998

5-HT4 derivative R-093877 enhances colonic transit in healthy volunteers

May 28, 1998

Oral immunization against H. pylori infection appears promising in mice

May 27, 1998

Factor XIII does not show clinical efficacy in patients with ulcerative colitis

May 27, 1998

Pharmos' neuroprotectant shows additional utility in IBD and anorexia

May 26, 1998

Synsorb Biotech expands phase II trial of Synsorb Cd

May 26, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...